产品名称 | NebuSelect™ Recombinant Human LAG3/CD223, hFc-tag |
---|---|
目录号 | NBL-242389 |
别名 | LAG3/CD223; CD223; FDC; LAG3; LAG-3; sLAG-3 |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P18627-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242389-100ug | 100ug | Inquire | Inquire | |
NBL-242389-1mg | 1mg | Inquire | Inquire | |
NBL-242389-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human LAG3/CD223, hFc-tag
Catalog#:
NBL-242389
Description:
NebuSelect™ Recombinant Human LAG3/CD223, hFc-tag(Cat#NBL-242389) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Leu23-Leu450.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 72.4 kDa. Due to glycosylation, the protein migrates to 75-80 kDa based on Bis-Tris PAGE result.
Target Name:
LAG3/CD223; CD223; FDC; LAG3; LAG-3; sLAG-3
Target Information:
LAG-3, is a protein which in humans is encoded by the LAG3 gene, which is a cell surface molecule with diverse biologic effects on T cell function. It is an immune checkpoint receptor and as such is the target of various drug development programs by pharmaceutical companies seeking to develop new treatments for cancer and autoimmune disorders.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.